Long-Term Assets: The sum of all assets classified as non-current.
Tempest Therapeutics, Inc. (TPST) had Long-Term Assets of $8.66M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.26M |
|
-- |
|
-- |
|
$26.57M |
|
$-26.57M |
|
$0.31M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.26M |
|
$-26.57M |
|
$-26.31M |
|
4.15M |
|
4.15M |
|
$-6.33 |
|
$-6.33 |
|
| Balance Sheet Financials | |
$8.27M |
|
$0.60M |
|
|
Long-Term Assets |
$8.66M |
$16.93M |
|
$3.31M |
|
-- |
|
$6.95M |
|
$10.26M |
|
$6.67M |
|
$6.67M |
|
$6.67M |
|
4.93M |
|
| Cash Flow Statement Financials | |
$-26.82M |
|
-- |
|
$4.26M |
|
$30.71M |
|
$8.15M |
|
$-22.56M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-393.85% |
|
-393.85% |
|
-155.11% |
|
-393.85% |
|
$1.35 |
|
$-6.46 |
|
$-6.46 |
|